4.4 Article

Safety evaluation of fish protein hydrolysate supplementation in malnourished children

Journal

REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 69, Issue 1, Pages 1-6

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2014.02.009

Keywords

Fish protein hydrolysate; Amizate (R); Safety; Growth; Malnutrition; Children

Funding

  1. Zymtech AS, Norway

Ask authors/readers for more resources

Amizate (R) is a proprietary protein hydrolysate preparation derived from Atlantic salmon (Salmo solar) using endogenous hydrolytic enzymes; it contains mostly free amino acids and short peptides, as well as small amounts of micronutrients (i.e., vitamins and minerals). In this study, the safety of supplementation with fish protein hydrolysate (Amizate (R)) was examined in 438 malnourished children in a randomized, placebo-controlled, double-blind, and parallel study. The children were between the ages of six to eight and met the Gomez classification for mild or moderate malnutrition. They were randomized to receive one of three interventions for four months, including a chocolate drink (control), or Amizate (3 or 6 g/day) in a chocolate drink. Administration of Amizate was well-tolerated, with no adverse events reported. Growth (i.e., body weight gain, changes in height, and body mass index) was not negatively impacted by administration of Amizate, and routine biochemical analysis of blood and urine samples did not reveal any abnormalities that were attributable to the intervention. Findings from this study demonstrate that daily consumption of 3 or 6 g of fish protein hydrolysate (Amizate (R)) was safe and suitable for supplementing the diets of malnourished children. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available